Droxidopa in Patients with Neurogenic Orthostatic Hypotension Associated with Parkinson's Disease (NOH306A)
Background: Neurogenic orthostatic hypotension (nOH) is common in Parkinson's disease (PD), and represents a failure to generate norepinephrine responses appropriate for postural change. Droxidopa (L-threo-3,4-dihydroxyphenylserine) is an oral norepinephrine prodrug. Objective: Interim analyses of t...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publishing
2014-02-01
|
| Schriftenreihe: | Journal of Parkinson’s Disease |
| Online-Zugang: | https://doi.org/10.3233/JPD-130259 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|